50FINANCE
⚡ Markets: A major divestiture for J&J, allowing it to focus on higher-growth pharma and medtech segments. Positive for JNJ stock if the valuation is favorable. A significant acquisition for Apollo.JNJAPO
Johnson & Johnson is reportedly in discussions to sell its hips-and-knees business to private equity firm Apollo Global Management. The potential deal is valued at around $20 billion.
West MSM: noneFinancial press 11 country
1 sources across the spectrum